For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
Implantation of an S-ICD in a Patient with a DDD Pacemaker and Congenitally Corrected Transposition of the Great Arteries In a new publication from Cardiovascular ...
In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
DAVID's shadow: MADIT II substudy supports theory that ventricular pacing in ICD patients promotes a
Washington, DC - Despite the vast improvement in mortality for those implanted with a device, the ICD population of the Multicenter Autonomic Defibrillator Implantation Trial II (MADIT II) had a ...
The overall primary composite endpoint of inappropriate shocks and complications came out nearly identical (HR 0.99, 95% CI 0.71-1.39, P=0.01 for noninferiority) over a median 4 years in the ...
"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback